Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Teleflex Wins First-Ever FDA Approval for Freeze Dried Plasma Product, Shares Tick Up Pre-Market

Teleflex Incorporated (NYSE:TFX) shares edged higher in pre-market trading after the company announced it received Biologics License Application approval from the FDA for EZPLAZ Freeze Dried Plasma. Teleflex is a Wayne, Pennsylvania-based global medical technology company that designs, develops, and supplies devices used in …

Nitish Kishor | 30 July 2026

Merck (NYSE:MRK) and Wellcome-Backed Hilleman Labs to Manufacture Bundibugyo Ebola Vaccine

Hilleman Laboratories, a Singapore-based joint venture between Merck (NYSE:MRK) and global charity Wellcome, is preparing to manufacture doses of an experimental vaccine targeting the rare Bundibugyo strain of Ebola, responsible for a rapidly spreading outbreak in the Democratic Republic of Congo. The effort is …

Nitish Kishor | 30 July 2026

Ocugen, Inc. (NASDAQ:OCGN) Gains Pre-Market Today on FDA Designation for Eye Disease Gene Therapy

Ocugen, Inc. (NASDAQ:OCGN) shares advanced in pre-market trading after the FDA granted Regenerative Medicine Advanced Therapy designation to OCU410, the company's investigational gene therapy for geographic atrophy. Ocugen is a Malvern, Pennsylvania-based biotechnology company developing modifier gene therapies for blindness diseases, taking a gene-agnostic …

Nitish Kishor | 30 July 2026

GSK (NYSE:GSK) Signs $110 Million AI Drug Discovery Deal With Relation Therapeutics

British biotech firm Relation Therapeutics has entered into a research collaboration with GSK (NYSE:GSK) worth up to $110 million, aimed at generating human cellular datasets and training artificial intelligence models to identify potential new drug targets. The agreement marks an expansion of an existing …

Nitish Kishor | 30 July 2026

Why Is Johnson & Johnson (NYSE:JNJ) Falling Pre-Market Despite Strong Q2 Results?

Johnson & Johnson (NYSE:JNJ) shares fell in pre-market trading after the company revised its earnings guidance lower to account for dilution from two recent business development transactions. Johnson & Johnson is a New Brunswick, New Jersey-based multinational pharmaceutical and medical technology corporation operating through …

Nitish Kishor | 30 July 2026

MiMedx Group Slides Pre-Market as Wound Care Decline and Acquisition Concerns Weigh on Shares

MiMedx Group, Inc. (NASDAQ:MDXG) shares declined in pre-market trading, extending losses from earlier in the week, after the company reported second-quarter results showing a sharp deterioration in its core wound care business. MiMedx is a Marietta, Georgia-based biotechnology company and pioneer in placental biologics, …

Nitish Kishor | 30 July 2026

Why Is Corcept Therapeutics Incorporated (NASDAQ:CORT) Up 22% Pre-Market Today?

Corcept Therapeutics Incorporated (NASDAQ:CORT) shares surged in pre-market trading after the company reported second-quarter results that significantly topped Wall Street expectations across both revenue and earnings. Corcept is a Redwood City, California-based commercial-stage biopharmaceutical company focused on discovering and developing drugs that modulate the …

Nitish Kishor | 30 July 2026

What's Behind Glaukos Corporation's (NYSE:GKOS) 8% Pre-Market Jump Today?

Glaukos Corporation (NYSE:GKOS) shares jumped in pre-market trading after the ophthalmic medical technology company delivered a second-quarter report that significantly exceeded Wall Street expectations. Glaukos is an Aliso Viejo, California-based company that pioneered the Micro-Invasive Glaucoma Surgery market with its iStent family of micro-bypass …

Nitish Kishor | 30 July 2026

Butterfly Network Shares Climb Pre-Market Ahead of Q2 Earnings Release

Butterfly Network, Inc. (NYSE:BFLY) shares traded higher in pre-market activity ahead of its second-quarter 2026 earnings release, with investors positioning around continued growth in the company's core ultrasound business. Butterfly is a Burlington, Massachusetts-based digital health company that develops, manufactures, and commercializes handheld, whole-body …

Nitish Kishor | 30 July 2026

Cerus Corporation (NASDAQ:CERS) Ticks Higher Pre-Market as Investors Await Second-Quarter Report

Cerus Corporation (NASDAQ:CERS) shares moved higher in pre-market trading ahead of its second-quarter 2026 earnings release, with investors positioning around the company's recent growth trajectory and progress toward profitability. Cerus is a Concord, California-based biomedical products company dedicated to safeguarding the world's blood supply …

Nitish Kishor | 30 July 2026
Support

Hi! How can we help you today?

Loading…